Long-Haul COVID-19 and T-Cell Activation
How does T-cell activation evolve following acute COVID-19 infection in patients with long-haul respiratory symptoms?
AAAAI 2022
COVID-19 Mortality and Obstructive Airway Diseases
How do comorbid asthma, COPD, and ACO affect COVID-19 outcomes?
Biologics and Aspirin-Exacerbated Respiratory Disease
A recent survey of patients with aspirin-exacerbated respiratory disease identified trends in patients’ medication use and treatment experience.
Biologics in Eosinophilic Asthma: Dupilumab vs Mepolizumab vs Benralizumab
What is the comparative effectiveness of biologics for treating eosinophilic asthma?
Respiratory Virus Infections and Pediatric Asthma Exacerbations
How have social distancing and other interventions to prevent the spread of COVID-19 affected pediatric asthma exacerbations?
Reducing the Frequency of Ongoing Peanut Oral Immunotherapy in Children
How does a short-term halt in peanut oral immunotherapy or a reduced dosing frequency affect children who have already received a year of peanut OIT?
Do Patients With Antibody Deficiency Benefit From COVID-19 Vaccine?
Can individuals who are antibody deficient produce SARS-CoV-2-specific CD4+ and CD8+ T cell responses to vaccination or infection?
Effect of Tezepelumab on Severe Asthma Symptoms in Adults and Adolescents
An analysis of phase 3 NAVIGATOR trial data assessed the effect of tezepelumab on the percentage of asthma symptomatic days in adults and adolescents.
Gut Microbiota, Diet, and Allergic Asthma Phenotypes in Children
How does consumption of processed food by children with atopy and asthma affect the gut microbiota and disease severity?
Peanut Oral Immunotherapy in Children Evaluated via Real World Study
Is peanut oral immunotherapy well-tolerated by children in the real world, and does tolerance vary by age or by peanut protein dosage?
- Loading...
Loading...
Next post in AAAAI 2022
Loading... 
Loading...